On Monday, Rite Aid Corporation (NYSE:RAD)’s shares declined -0.13% to $7.85.
Robbins Geller Rudman & Dowd LLP declared that a class action has been commenced in the United States District Court for the Middle District of Pennsylvania on behalf of shareholders of Rite Aid Corporation (“Rite Aid”) (RAD) on October 27, 2015, in connection with the projected acquisition of Rite Aid by Walgreens Boots Alliance, Inc. (“Walgreens”) (the “Projected Transaction”).
If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from recently. If you wish to talk about this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Darren Robbins of Robbins Geller at 800/449-4900 or 619/231-1058, or via e-mail at [email protected]. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
The complaint charges Rite Aid, its Board of Directors (the “Board”), Walgreens and certain associates of Walgreens with violations of the Securities Exchange Act of 1934 (“1934 Act”). Rite Aid is a retail drugstore chain that sells prescription drugs and a range of other merchandise referred to as “front-end products.”
On October 27, 2015, Rite Aid and Walgreens jointly declared that they had reached a contract and Plan of Merger following which Walgreens will purchase Rite Aid for $9.00 per share in cash. The Projected Transaction is valued at $17.2 billion.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
NRG Energy Inc (NYSE:NRG)’s shares dropped -1.13% to $11.37. The last trading range of NRG Energy Inc (NYSE:NRG) ranges between $11.06 and $11.58. The EPS of the company stands at $-0.04. The 52-week range shows that the stock reached higher at $28.39 while its lower range is $8.80 in the last 52-weeks. The average volume of the company is at 9.86 million with the Outstanding Shares of 314.18 million. The market capitalization of the company is $3.61 billion. The Beta of the company stands at 0.72 with the RSI (Relative Strength Index) of 53.19.
NRG Energy, Inc., together with its auxiliaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, and on-site energy solutions; carbon administration and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset administration services. It owns and operates about 52,000 MWs of generation.
Allergan plc Ordinary Shares (NYSE:AGN)‘s shares dipped -0.76% to $308.88. Allergan plc Ordinary Shares (NYSE:AGN) is now worth about $122.69 billion. The share price has made a 0.75% gain in the past 5 days and has gained 20% since 2015 kicked off. Analysts are forecasting EPS growth of -6.77% for next fiscal year and 9.00% growth in the next 5 years. The stock trades with a beta of 0.68. The stock price is above by 2.55% as contrast to the average price over the last 200 days. The company has 63.00% gross margins.
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
